InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Davis Andrew. Insider active across 1 company, notably Ironwood Pharmaceuticals INC. In total, 9 filings have been published. Split: 0 buy · 7 sells. Total volume traded: €439k. Activity tracked since 21 November 2022. The latest transaction was disclosed on 18 November 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Davis Andrew is SVP, Chief Business Officer at Ironwood Pharmaceuticals INC (XNAS). There have been 9 filings in total, and across the 9 sampled recent filings between 2022-11-23 and 2024-11-20, the transactions are all sales, for a total of EUR 439149.